** Shares of Australia's Tetratherix TTX.AX rise as much as 15.3% to A$3.320 on trading debut, compared with their IPO offer price of A$2.88 per share
** Firm lists on the ASX to accelerate development of its polymer platform technology, Tetramatrix
** Co raised A$25 million ($16.33 million) in its IPO, valuing it at A$145 million
** TTX has developed a proprietary fluid matrix that is invisible to the body and does not induce any foreign bodily reaction to evolve regenerative medicine and targeted therapeutic delivery
** TTX shares pare early surge to climb 0.7% at A$2.90, compared with 0.4% gain in the ASX200 benchmark index .AXJO
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。